Exercise-Induced Anaphylaxis: Mast Cell Triggers and the Limits of Predictability Beyond Food Allergens

While the MedicalXpress report accurately outlines exercise-induced anaphylaxis (EIA) basics and its food-dependent subtype, it underplays the mechanistic uncertainty and diagnostic challenges that peer-reviewed work highlights. Mast cell degranulation remains the leading hypothesis, yet no RCT has isolated exercise as the sole variable; instead, evidence draws from small observational cohorts. A 10-year follow-up study (n=32) published in the Journal of Allergy and Clinical Immunology (Shadick et al., 1999, observational, no industry conflicts reported) found symptom stabilization in most patients, but this likely reflects avoidance behavior rather than disease remission. Oral immunotherapy trials (e.g., the 2019 PALISADE RCT extension, n=372 for peanut) demonstrate that moderate exercise can halve the threshold dose for reaction, yet even here only 40-60% of challenges provoked EIA, exposing unidentified cofactors such as hormonal shifts or subclinical infections. The source misses connections to broader mast cell activation syndromes, where EIA overlaps with cholinergic urticaria in up to 30% of cases per a 2022 systematic review in Allergy (observational data, sample sizes <200). Rising aerobic activity post-pandemic may unmask latent cases, but without standardized exercise challenge protocols—ethically limited by anaphylaxis risk—prevalence estimates (2.3-5%) remain imprecise. Clinicians should prioritize trigger diaries over single tests, as EIA unpredictability persists despite mast cell stabilization therapies like cromolyn showing promise in case series.